Cambridge Healthtech Institute’s Inaugural

Biologics for Immunology Indications

New Science and Conversations to Empower the Next Wave of Immunological Therapies

May 12-13, 2025

The new PEGS Biologics for Immunology Indications conference provides research scientists a platform for exploring the latest advancements in preclinical research for immunological diseases. This conference will highlight new strategies for addressing complex conditions such as autoimmunity, chronic inflammation, and rare diseases. Attendees will delve into innovative approaches for targeting immune pathways and developing novel therapeutic strategies. This session aims to foster collaboration and knowledge exchange, focusing on the practical aspects of early-stage research that drive progress in biologic development.

Coverage will include, but is not limited to:

Clinical and Translational Issues

Applications of surrogate markers in research and regulatory filings
Biomarkers, companion diagnostics, and personalized medicine
Clinical strategies for follow-on indications
Regulatory strategies

Biotherapeutics for Unmet and Underserved Medical Needs

Atopic Dermatitis and psoriasis
COPD
CV diseases with inflammatory components: atherosclerosis and myocarditis
Fibrotic diseases
IBD, Crohn’s disease, ulcerative colitis
Infectious diseases with chronic outcomes
Neurodegenerative diseases
Rare and orphan diseases
Type 1 Diabetes (T1D)

Emerging Targeting Strategies

Adaptive immune cells
Cytokine signaling
Cell-based therapies and immune engagers
Modulating immune checkpoints and effector cells in autoimmunity
Next-generation receptor and FcRn modulation
Targeted protein degradation

Multimodal Treatment Strategies

Bi- and multi-specific antibodies
Combination therapies
Next generation conjugates

Strategies and Modalities for Core Pathologies

Autoimmunity
Chronic inflammation
Neuroinflammation
Tissue regeneration and repair

The deadline for priority consideration is October 11, 2024.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: